相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease
W. J. Sandborn et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease
M. A. Kamm et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Dosage Adjustment During Long-term Adalimumab Treatment for Crohn's Disease: Clinical Efficacy and Pharmacoeconomics
William J. Sandborn et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
R. Panaccione et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
Abderrahim Oussalah et al.
CURRENT DRUG TARGETS (2010)
Environmental risk factors in Crohn's disease and ulcerative colitis: an update
F. Carbonnel et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2009)
Adalimumab for the treatment of fistulas in patients with Crohn's disease
J-F Colombel et al.
GUT (2009)
The genetics and immunopathogenesis of inflammatory bowel disease
Judy H. Cho
NATURE REVIEWS IMMUNOLOGY (2008)
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W. J. Sandborn et al.
GUT (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
分享论文
